RecruitingNCT06342557

Transitional ePRO Diary Liver (Transitional-ePRO)

Integrated System for Patients Who Belong the Transition to Adult Services and Are Undergoing a Liver Transplant


Sponsor

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Enrollment

250 participants

Start Date

Mar 28, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study is part of the MACROLIVER Project, whose main objective is to create a digital tool for patients and caregivers for the management of liver disease that allows the optimization of therapy and/or the treatment process, even remotely. Such a tool not only reduces the movement of patients who are by definition fragile, but also enables the optimization of access and care by a multidisciplinary team. This tool is intended to support doctors and patients, but in no way replaces normal clinical practice. This study aims to explore the specificities of patients experiencing the transition from the pediatric ward to the adult ward in order to identify risk and protective factors that influence psychological well-being at both an individual and relational level. In order to gather all the information about the patients attending the transitional clinic and to obtain a more complete and truthful clinical-psychological picture, the study also includes the collection of retrospective data of the transplanted patients.


Eligibility

Min Age: 14 YearsMax Age: 20 Years

Inclusion Criteria3

  • patients between the ages of 14 and 20 who have been transplanted at the ASST-PG23 transplant center or are awaiting a liver transplant and belong to the transition to adult services
  • signed informed consent
  • proven use of the APPs (to be assessed based on the last 2 weeks)

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

ASST-Papa Giovanni XXIII

Bergamo, MILANO, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06342557


Related Trials